Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'POSTMARKETING SURVEILLANCE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 136 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Madi, JC; Oigman, W; Franco, R; Armaganijan, D
      Valsartan alone and as part of combination therapy in general practice in Brazil

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. Roth, T; Hajak, G; Ustun, TB
      Consensus for the pharmacological management of insomnia in the new millennium

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    3. van Puijenbroek, EP; Egberts, ACG; Meyboom, RHB; Leufkens, HGM
      Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    4. Kuiper, HA; Kleter, GA; Noteborn, HPJM; Kok, EJ
      Assessment of the food safety issues related to genetically modified foods

      PLANT JOURNAL
    5. Petzke, F; Radbruch, L; Sabatowski, R; Karthaus, M; Mertens, A
      Slow-release tramadol for treatment of chronic malignant pain - an open multicenter trial

      SUPPORTIVE CARE IN CANCER
    6. Safer, DJ; Zito, JM; Gardner, JF
      Pemoline hepatotoxicity and postmarketing surveillance

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    7. Slough, CL; Miday, RK; Zorich, NL; Jones, JK
      Postmarketing surveillance of new food ingredients: Design and implementation of the program for the fat replacer olestra

      REGULATORY TOXICOLOGY AND PHARMACOLOGY
    8. Kubota, K; Kawabe, E; Hinotsu, S; Hamada, C; Ohashi, Y; Kurokawa, K
      Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    9. Neuhouser, ML; Rock, CL; Eldridge, AL; Kristal, AR; Patterson, RE; Cooper, DA; Neumark-Sztainer, D; Cheskin, LJ; Thornquist, MD
      Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents

      JOURNAL OF NUTRITION
    10. Rogalski, C; Hurlimann, A; Burg, G; Wuthrich, B; Kempf, W
      Terbinafine-induced acute generalized exanthematous pustulosis

      HAUTARZT
    11. Wong, ICK; Mawer, GE; Sander, JWAS
      Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom

      EPILEPSIA
    12. Clark, LT
      Safety profile of perindopril

      AMERICAN JOURNAL OF CARDIOLOGY
    13. Noah, BA
      Adverse drug reactions: Harnessing experiential data to promote patient welfare

      CATHOLIC UNIVERSITY LAW REVIEW
    14. Benson, JO; McGhee, K; Coplan, P; Grunfeld, C; Robertson, M; Brodovicz, KG; Slater, E
      Fat redistribution in indinavir-treated patients with HIV infection: A review of postmarketing cases

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Kristal, AR; Vizenor, NC; Patterson, RE; Neuhouser, ML; Shattuck, AL; McLerran, D
      Precision and bias of food frequency-based measures of fruit and vegetableintakes

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    16. Colebatch, KA; Marley, J; Doecke, C; Miles, HB; Gilbert, A
      Evaluation of a patient event report monitoring system

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    17. Levine, MAH; Grootendorst, P
      Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    18. Coulter, DM
      The New Zealand Intensive Medicines Monitoring Programme in pro-active safety surveillance

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    19. Gauld, NJ; Shaw, JP; Emmerton, LM; Pethica, BD
      Surveillance of a recently switched non-prescription medicine (Diclofenac)using a pharmacy-based approach

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    20. Shipton, EA
      Tramadol - Present and future

      ANAESTHESIA AND INTENSIVE CARE
    21. Gardner, JS; Blough, D; Drinkard, CR; Shatin, D; Anderson, G; Graham, D; Alderfer, R
      Tramadol and seizures: A surveillance study in a managed care population

      PHARMACOTHERAPY
    22. Wiedmann, M; Liebert, UG; Oesen, U; Porst, H; Wiese, M; Schroeder, S; Halm, U; Mosser, J; Berr, F
      Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C

      HEPATOLOGY
    23. Smith, EB
      The treatment of dermatophytosis: Safety considerations

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    24. Irl, C; Hasford, J
      Assessing the safety of drugs in pregnancy - The role of prospective cohort studies

      DRUG SAFETY
    25. Currie, CJ; MacDonald, TM
      Use of routine healthcare data in safe and cost-effective drug use

      DRUG SAFETY
    26. Bywater, RJ
      Sense and nonsense in surveillance programs

      ACTA VETERINARIA SCANDINAVICA
    27. Leufkens, HG
      Pharmacoepidemiology and gastroenterology: a close couple

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    28. Thornquist, MD; Kristal, AR; Patterson, RE; Neuhouser, ML; Rock, CL; Neumark-Sztainer, D; Cheskin, LJ
      Olestra consumption does not predict serum concentrations of carotenoids and fat-soluble vitamins in free-living humans: Early results from the sentinel site of the olestra post-marketing surveillance study

      JOURNAL OF NUTRITION
    29. Patterson, RE; Kristal, AR; Peters, JC; Neuhouser, ML; Rock, CL; Cheskin, LJ; Neumark-Sztainer, D; Thornquist, MD
      Changes in diet, weight, and serum lipid levels associated with olestra consumption

      ARCHIVES OF INTERNAL MEDICINE
    30. Neuhouser, ML; Patterson, RE; Kristal, AR; Rock, CL; Neumark-Sztainer, D; Thornquist, MD; Cheskin, LJ
      Do consumers of savory snacks have poor-quality diets?

      JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
    31. Sobo, EJ; Rock, CL; Neuhouser, ML; Maciel, TL; Neumark-Sztainer, D
      Caretaker-child interaction during children's 24-hour dietary recalls: Whocontributes what to the recall record?

      JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
    32. Kubota, K
      A design for Prescription-Event Monitoring in Japan (J-PEM)

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    33. Czeizel, AE
      The role of pharmacoepidemiology in pharmacovigilance: Rational drug use in pregnancy

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    34. Dunn, N; Mann, RD
      Prescription-event and other forms of epidemiological monitoring of side-effects in the UK

      CLINICAL AND EXPERIMENTAL ALLERGY
    35. Gupta, AK; Shear, NH
      The new oral antifungal agents for onychomycosis of the toenails

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    36. Olsen, H; Klemetsrud, T; Stokke, HP; Tretli, S; Westheim, A
      Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway

      BLOOD PRESSURE
    37. Cicero, TJ; Adams, EH; Geller, A; Inciardi, JA; Munoz, A; Schnoll, SH; Senay, EC; Woody, GE
      A postmarketing surveillance program to monitor Ultram (R) (tramadol hydrochloride) abuse in the United States

      DRUG AND ALCOHOL DEPENDENCE
    38. Beggs, PW; Clark, DWJ; Williams, SM; Coulter, DM
      A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    39. Singleton, JA; Lloyd, JC; Mootrey, GT; Salive, ME; Chen, RT
      An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system

      VACCINE
    40. Strohle, A; Antonijevic, IA; Steiger, A; Sonntag, A
      Dependency of non-benzodiazepine hypnotics. Two case reports

      NERVENARZT
    41. Vlug, AE; van der Lei, J; Mosseveld, BMT; van Wijk, MAM; van der Linden, PD; Sturkenboom, MCJM; van Bemmel, JH
      Postmarketing surveillance based on electronic patient records: The IPCI project

      METHODS OF INFORMATION IN MEDICINE
    42. Pillans, PI; Mathew, TH; Coulter, DM
      Pharmacovigilance in Australia and New Zealand: towards 2000

      MEDICAL JOURNAL OF AUSTRALIA
    43. Gupta, AK; Shear, NH
      Safety review of the oral antifungal agents used to treat superficial mycoses

      INTERNATIONAL JOURNAL OF DERMATOLOGY
    44. O'Sullivan, DP
      Terbinafine: tolerability in general medical practice

      BRITISH JOURNAL OF DERMATOLOGY
    45. Mullooly, J; Drew, L; DeStefano, F; Chen, R; Okoro, K; Swint, E; Immanuel, V; Ray, P; Lewis, N; Vadheim, C; Lugg, M
      Quality of HMO vaccination databases used to monitor childhood vaccine safety

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    46. Haneke, E
      Tongue burns and terbinafine

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    47. BERESFORD J; COLINJONES DG; FLIND AC; LANGMAN MJS; LAWSON DH; LOGAN RFA; PATERSON KR; VESSEY MP
      POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 15-YEAR MORTALITY REPORT

      Pharmacoepidemiology and drug safety
    48. MCMAHON AD; EVANS JMM; MCGILCHRIST MM; MCDEVITT DG; MACDONALD TM
      DRUG EXPOSURE RISK WINDOWS AND UNEXPOSED COMPARATOR GROUPS FOR COHORTSTUDIES IN PHARMACOEPIDEMIOLOGY

      Pharmacoepidemiology and drug safety
    49. PEREIRA SP; WILLIAMS R
      ADVERSE EVENTS ASSOCIATED WITH VITAMIN-K-1 - RESULTS OF A WORLDWIDE POSTMARKETING SURVEILLANCE PROGRAM

      Pharmacoepidemiology and drug safety
    50. COULTER DM
      THE NEW-ZEALAND INTENSIVE MEDICINES MONITORING PROGRAM

      Pharmacoepidemiology and drug safety
    51. RATHMANN W; HAASTERT B; DELLING B; GRIES FA; GIANI G
      POSTMARKETING SURVEILLANCE OF ADVERSE DRUG-REACTIONS - A CORRELATIONAL STUDY APPROACH USING MULTIPLE DATA SOURCES

      Pharmacoepidemiology and drug safety
    52. ANDREJAK M; GERSBERG M; SGRO C; DECOCQ G; HAMEL JD; MORIN M; GRAS V
      FRENCH PHARMACOVIGILANCE SURVEY EVALUATING THE HEPATIC TOXICITY OF COUMARIN

      Pharmacoepidemiology and drug safety
    53. BAIER D
      PARTICULAR ASPECTS OF ADVERSE EVENT ASSESSMENT IN POST MARKETING SURVEILLANCE

      European psychiatry
    54. MARTIN RM; BISWAS PN; FREEMANTLE SN; PEARCE GL; MANN RD
      AGE AND SEX DISTRIBUTION OF SUSPECTED ADVERSE DRUG-REACTIONS TO NEWLYMARKETED DRUGS IN GENERAL-PRACTICE IN ENGLAND - ANALYSIS OF 48 COHORTSTUDIES

      British journal of clinical pharmacology
    55. KING DJ; WAGER E
      HEMATOLOGICAL SAFETY OF ANTIPSYCHOTIC-DRUGS

      JOURNAL OF PSYCHOPHARMACOLOGY
    56. HAJAK G; BANDELOW B
      SAFETY AND TOLERANCE OF ZOLPIDEM IN THE TREATMENT OF DISTURBED SLEEP - A POSTMARKETING SURVEILLANCE OF 16944 CASES

      International clinical psychopharmacology
    57. Goldman, SA
      Limitations and strengths of spontaneous reports data

      CLINICAL THERAPEUTICS
    58. SARNOW E; PFRUNDER D
      AZITHROMYCIN IN PATIENTS WITH RESPIRATORY -TRACT INFECTIONS

      Wiener Klinische Wochenschrift
    59. HASFORD J; LAMPRECHT T
      COMPANY OBSERVATIONAL POSTMARKETING STUDIES - DRUG RISK ASSESSMENT AND DRUG RESEARCH IN SPECIAL POPULATIONS - A STUDY-BASED ANALYSIS

      European Journal of Clinical Pharmacology
    60. ONRUST SV; LAMB HM; BALFOUR JAB
      OFLOXACIN - A REAPPRAISAL OF ITS USE IN THE MANAGEMENT OF GENITOURINARY TRACT INFECTIONS

      Drugs
    61. FERNANDEZ L; MAS R; ILLNAIT J; FERNANDEZ JC
      POLICOSANOL - RESULTS OF A POSTMARKETING SURVEILLANCE STUDY OF 27,879PATIENTS

      Current therapeutic research
    62. Bigby, M
      Evidence-based medicine in a nutshell - A guide to finding and using the best evidence in caring for patients

      ARCHIVES OF DERMATOLOGY
    63. BERDAH J; GUEST M; SALVADOR M
      STUDY OF THE EFFICACY AND SAFETY OF FOSIN OPRIL IN GENERAL-PRACTICE IN 19,435 HYPERTENSIVE PATIENTS (FLIGHT STUDY)

      Annales de cardiologie et d'angeiologie
    64. Imbs, JL; Castot, A; Begaud, B; Larousse, C; Blayac, JP; Alexandre, JM
      Pharmacovigilance in France

      BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    65. YOUNG LR; WURTZBACHER JD; BLANKENSHIP CS
      ADVERSE DRUG-REACTIONS - A REVIEW FOR HEALTH-CARE PRACTITIONERS

      American journal of managed care
    66. SUND KG; CARLO CL
      WIRELESS TECHNOLOGY RESEARCH, LLC ONGOING SURVEILLANCE

      Human and ecological risk assessment
    67. MACKAY FJ; DUNN NR; WILTON LV; PEARCE GL; FREEMANTLE SN; MANN RD
      A COMPARISON OF FLUVOXAMINE, FLUOXETINE, SERTRALINE AND PAROXETINE EXAMINED BY OBSERVATIONAL COHORT STUDIES

      Pharmacoepidemiology and drug safety
    68. EGBERTS ACG; DEKONING FHP; MEYBOOM RHB; LEUFKENS HGM
      ADR RELATED QUESTIONS RECEIVED BY A TELEPHONE MEDICINES INFORMATION-SERVICE AND ADRS RECEIVED BY A SPONTANEOUS ADR REPORTING SYSTEM - A COMPARISON REGARDING PATIENTS AND DRUGS

      Pharmacoepidemiology and drug safety
    69. MITTMANN N; LIU BA; ISKEDJIAN M; BRADLEY CA; PLESS R; SHEAR NH; EINARSON TR
      DRUG-RELATED MORTALITY IN CANADA (1984-1994)

      Pharmacoepidemiology and drug safety
    70. FRIEDMAN GD
      LINDANE AND CANCER IN HUMANS - A FALSE ALARM

      Pharmacoepidemiology and drug safety
    71. MANN RD; WILTON LV; PEARCE GL; MACKAY FJ; DUNN NR
      PRESCRIPTION-EVENT MONITORING (PEM) IN 1996 - A METHOD OF NON-INTERVENTIONAL OBSERVATIONAL COHORT PHARMACOVIGILANCE

      Pharmacoepidemiology and drug safety
    72. HARTMANN K; CIORCIARO C; KUHN M
      SIGNAL GENERATION IN A NON-EU COUNTRY

      Pharmacoepidemiology and drug safety
    73. WALKER AM; LANZA LL; ARELLANO F; ROTHMAN KJ
      MORTALITY IN CURRENT AND FORMER USERS OF CLOZAPINE

      Epidemiology
    74. MEYBOOM RHB
      GOOD PRACTICE IN THE POSTMARKETING SURVEILLANCE OF MEDICINES

      Pharmacy world & science
    75. LEVINE MAH; HAMET P; NOVOSEL S; JOLAIN B
      A PROSPECTIVE COMPARISON OF 4 STUDY DESIGNS USED IN ASSESSING SAFETY AND EFFECTIVENESS OF DRUG-THERAPY IN HYPERTENSION MANAGEMENT

      American journal of hypertension
    76. WOBER W; CRESPO CD; BAHRE M
      EFFICACY AND TOLERABILITY OF AZELASTINE NASAL SPRAY IN THE TREATMENT OF ALLERGIC RHINITIS - LARGE-SCALE EXPERIENCE IN COMMUNITY PRACTICE

      Current medical research and opinion
    77. VANBOXTEL CJ; WANG G
      SOME OBSERVATIONS ON PHARMACOEPIDEMIOLOGY IN EUROPE

      Netherlands journal of medicine
    78. EGBERTS ACG; LENDERINK AW; DEKONING FHP; LEUFKENS HGM
      CHANNELING OF 3 NEWLY INTRODUCED ANTIDEPRESSANTS TO PATIENTS NOT RESPONDING SATISFACTORILY TO PREVIOUS TREATMENT

      Journal of clinical psychopharmacology
    79. ZANINELLI R; MEISTER W
      THE TREATMENT OF DEPRESSION WITH PAROXETINE IN PSYCHIATRIC PRACTICE IN GERMANY - THE POSSIBILITIES AND CURRENT LIMITATIONS OF DRUG-MONITORING

      Pharmacopsychiatry
    80. GEXFABRY M; BALANTGORGIA AE; BALANT LP
      THERAPEUTIC DRUG-MONITORING DATABASES FOR POSTMARKETING SURVEILLANCE OF DRUG-DRUG INTERACTIONS - EVALUATION OF A PAIRED APPROACH FOR PSYCHOTROPIC MEDICATION

      Therapeutic drug monitoring
    81. WAGER E; TOOLEY PJH; PEARCE GL; WILTON LV; MANN RD
      A COMPARISON OF 2 COHORT STUDIES EVALUATING THE SAFETY OF CISAPRIDE -PRESCRIPTION-EVENT MONITORING AND A LARGE PHASE-IV STUDY

      European Journal of Clinical Pharmacology
    82. JOUGLARD J; HAMEL JD; JUVIN P
      A PHARMACOEPIDEMIOLOGIC STUDY OF TRANDOLAPRIL

      Current therapeutic research
    83. MODELL JG; KATHOLI CR; MODELL JD; DEPALMA RL
      COMPARATIVE SEXUAL SIDE-EFFECTS OF BUPROPION, FLUOXETINE, PAROXETINE,AND SERTRALINE

      Clinical pharmacology and therapeutics
    84. EDWARDS C; BLOWERS DA; POVER GM
      FOSINOPRIL NATIONAL SURVEY - A POSTMARKETING SURVEILLANCE STUDY OF FOSINOPRIL (STARIL(TM)) IN GENERAL-PRACTICE IN THE UK

      International journal of clinical practice
    85. OLIVERIA SA; FELSON DT; KLEIN RA; REED JI; WALKER AM
      ESTROGEN REPLACEMENT THERAPY AND THE DEVELOPMENT OF OSTEOARTHRITIS

      Epidemiology

    86. CUTANEOUS REACTIONS TO ALIMENTARY-TRACT MEDICATIONS - RESULTS OF A 7-YEAR SURVEILLANCE PROGRAM AND REVIEW OF THE LITERATURE

      Dermatology
    87. GABRIEL SE; CROWSON CS; OFALLON WM
      A MATHEMATICAL-MODEL THAT IMPROVES THE VALIDITY OF OSTEOARTHRITIS DIAGNOSES OBTAINED FROM A COMPUTERIZED DIAGNOSTIC DATABASE

      Journal of clinical epidemiology
    88. BERBER AC; DELRIONAVARRO BE
      USE OF BRONCHO-VAXOM(R) IN PRIVATE-PRACTICE - PHASE-IV TRIAL IN 587 CHILDREN

      Clinical therapeutics
    89. OVERLACK A
      ACE INHIBITOR-INDUCED COUGH AND BRONCHOSPASM - INCIDENCE, MECHANISMS AND MANAGEMENT

      Drug safety
    90. BIRON P; BALENCY D
      QUEBEC JOINT PHARMACOVIGILANCE PROGRAM - COMPARISON OF SPONTANEOUS REPORTING WITH FRANCE, AQUITAINE AND THE BASQUE COUNTRY

      Therapie
    91. BEUCHARD J; BENETON C; ALLAIN H
      HOW DOES PHARMACOVIGILANCE WORK

      La Semaine des hopitaux de Paris
    92. OTTERVANGER JP; VALKENBURG HA; GROBBEE DE; STRICKER BH
      PATTERN OF SUMATRIPTAN USE AND OVERUSE IN GENERAL-PRACTICE

      European Journal of Clinical Pharmacology
    93. KUBOTA K; KUBOTA N; PEARCE GL; INMAN WHW
      ACE-INHIBITOR INDUCED COUGH, AN ADVERSE DRUG REACTION UNRECOGNIZED FOR SEVERAL YEARS - STUDIES IN PRESCRIPTION-EVENT MONITORING

      European Journal of Clinical Pharmacology
    94. SOTO J
      THE FUTURE OF DRUG SURVEILLANCE IN SPAIN - THE NEED FOR JOINING EFFORTS

      Medicina Clinica
    95. SOTO J; SACRISTAN JA; ALSAR MJ; GALENDE I
      PHARMACO-SURVEILLANCE WITHIN THE PHARMACE UTICAL-INDUSTRY - PRESENT AND FUTURE

      Medicina Clinica
    96. WILTON L; PEARCE G; EDET E; FREEMANTLE S; STEPHENS MDB; MANN RD
      THE SAFETY OF FINASTERIDE USED IN BENIGN PROSTATIC HYPERTROPHY - A NON-INTERVENTIONAL OBSERVATIONAL COHORT STUDY IN 14772 PATIENTS

      British Journal of Urology
    97. MULLOOLY JP
      MISCLASSIFICATION MODEL FOR PERSON-TIME ANALYSIS OF AUTOMATED MEDICAL-CARE DATABASES

      American journal of epidemiology
    98. FLETCHER AP
      THE DEMISE OF POSTMARKETING SURVEILLANCE

      Adverse drug reactions and toxicological reviews
    99. FLETCHER AP
      APPROACHING A CENTURY AND AFTER - MORBIDITY AND POTENTIALLY DRUG-INDUCED DISEASE

      Adverse drug reactions and toxicological reviews
    100. KUBOTA K; KUBOTA N; PEARCE GL; PRESCOTT P; MANN RD
      SIGNALING DRUG-INDUCED RASH WITH 36 DRUGS RECENTLY MARKETED IN THE UNITED-KINGDOM AND STUDIED BY PRESCRIPTION-EVENT MONITORING

      International journal of clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 03:05:59